Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Sanofi-Aventis ADS (NY: SNY)
54.25 USD  -0.31 (-0.57%)
Streaming Delayed Price  /  Updated: 1:16 PM EDT, Jun 19, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Sanofi-Aventis ADS
 
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Trading Idea: Momentum Building in Sanofi-Aventis
Today 9:20 EDT
New York, June 19th (TradersHuddle.com) - Shares of Sanofi-Aventis ( NYSE:SNY ) closed the trading session at $54.56 with its price action in a very tight range, given that calculated support is set at... Read More
from TradersHuddle.com
Trading Idea: Entry Levels for Sanofi-Aventis
June 18, 2013
New York, June 18th (TradersHuddle.com) - Shares of Sanofi-Aventis ( NYSE:SNY ) ended the trading session close to calculated support at $52.37, a level that will raise the attention of traders looking... Read More
from TradersHuddle.com
Pharma Stocks: Court Ruling's Real Meaning
June 17, 2013
category AZN , SNY , MRK , and 4 more.
from YCharts
Leading Experts in Parenting, Education and Medicine Partner to Launch Head Lice Awareness Initiative
June 17, 2013
- Headfirst! Expert Advice on Lice Offers Moms and Healthcare Providers Helpful Tools and Resources to Overcome Head Lice - Read More
from PR Newswire
Close to the 50 Day Moving Average: Sanofi-Aventis
June 14, 2013
New York, June 14th (TradersHuddle.com) - Sanofi-Aventis ( NYSE:SNY ) closed the trading day at $53.99, near its 50 day moving average that is set at $53.63. Sanofi-Aventis' price action is just above... Read More
from TradersHuddle.com
Verastem directors buy $475K of stock, company set for potential pivotal trials
June 13, 2013
Three directors of cancer drug company Verastem Inc. and its founding executive chairman have purchased $475,000 worth of the company’s stock in the past week as it plans to start a potential pivotal... Read More
category Genzyme Corp/ , U/S/ Food and Drug Administration , John Clarke , and 10 more.
from Business Journals
PPH, NVS, SNY, GSK: ETF Inflow Alert
June 12, 2013
Symbols mentioned in this story: PPH, NVS, SNY, GSK Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
category ETFs
from ETF Channel
Bullish Moving Average Cross by Sanofi-Aventis (SNY)
June 12, 2013
from Comtex SmarTrend® News Briefs
Sanofi-Aventis Is Approaching its 50 Day Moving Average
June 12, 2013
New York, June 12th (TradersHuddle.com) - Sanofi-Aventis ( NYSE:SNY ) ended the trading session at $52.99, near its 50 day moving average set at $53.55. Sanofi-Aventis' price action placed the stock... Read More
from TradersHuddle.com
Providing Quality Healthcare Through Long-term Investments, Divestitures, New Research, Clinical Trials Results - Research Report on AmerisourceBergen, Zoetis, AstraZeneca, Cardinal Health and Sanofi
June 12, 2013
Editor Note: For more information about this release, please scroll to bottom Read More
from PR Newswire
Genzyme Convenes 14th Annual North American Lysosomal Storage Disorder Registries Meeting
June 12, 2013
from Business Wire News Releases
All Penny Stocks.com News: Advaxis Aims for Orphan Drug Status in Cervical and Head and Neck Cancers
June 11, 2013
Mississauga, ON -- (SBWIRE) -- 06/11/2013 -- AllPennyStocks.com Media, Inc. (AllPennyStocks.com/) announces its latest article titled “Advaxis Aims for Orphan Drug Status in Cervical and Head and Neck... Read More
from SBWire - Latest Press Releases
New Four-Strain Influenza Vaccine from Sanofi Pasteur Now Licensed By FDA for Broad Age Range of Children and Adults
June 10, 2013
New Fluzone® Quadrivalent (Influenza Virus Vaccine): Read More
from PR Newswire
Top-Performing Dividend Payers in Health Care with the Most Upside Potential (AET, ENSG, QCOR)
June 08, 2013
It is not unusual for stocks on a tear to overrun their mean price targets, which is a signal of how far analysts on average expect the share price to climb. Some of the top-performing health care... Read More
category skilled healthcare group , Benzinga , Trading Ideas , and 25 more.
from Latest Articles from Benzinga.com
What The FDA's Avandia Vote Means For The Future
June 06, 2013
Avandia, once the most-used diabetes pill on the planet, was all but finished. After concerns emerged that it might cause heart attacks, the Food and Drug Administration in 2010 put severe restrictions... Read More
category NYSE:MRK , NYSE:SNY , NYSE:NVO , and 2 more.
from Forbes Real Time
Sanofi-Aventis near Support
June 05, 2013
New York, June 5th (TradersHuddle.com) - Shares of Sanofi-Aventis ( NYSE:SNY ) ended the trading session close to calculated support at $52.51, a level that will raise the attention of traders looking... Read More
from TradersHuddle.com
Emmy® Award-Winning Actress Sarah Michelle Gellar Joins March of Dimes and Sanofi Pasteur on the Sounds of Pertussis® Campaign
June 05, 2013
Campaign Continues to Educate Adults on How to Help Protect Themselves and How to Help Stop the Spread of Pertussis to Infants Read More
from PR Newswire
Battleground FDA: How Tomorrow's Avandia Panel Could Help Shape The Future Of Diabetes
June 04, 2013
Avandia, once the best-selling diabetes pill on the planet, is now given only to a few thousand Americans. In much of the rest of the world it has been pulled from the market because of analyses that... Read More
category NYSE:SNY , NYSE:NVO , NYSE:GSK , and 2 more.
from Forbes Real Time
Pre-Market Analysis on VVUS, SNY, XRAY, and ACUR
June 04, 2013
from ACCESSWIRE
It’s Hard to Win the Pharma News Game
June 04, 2013
 Read More
category Market Outlook , NYSE:SNY , NASDAQ:ONXX , and 1 more.
from InvestorPlace - Latest Headlines
Sanofi US Announces Winner of 2013 Data Design Diabetes Innovation Challenge -- Prove It!
June 04, 2013
- Connect & Coach™ Awarded $100,000 to Further Develop its Novel Solution to Help Improve Health Outcomes for People Living with Diabetes - Read More
from PR Newswire
Trading the Setup In Sanofi-Aventis
June 04, 2013
New York, June 4th (TradersHuddle.com) - Sanofi-Aventis ( NYSE:SNY ) ended the trading session at $53.22, near its 50 day moving average set at $53.2466. Sanofi-Aventis' price action placed the stock... Read More
from TradersHuddle.com
Merrimack (MACK) Says MM-121 Phase 1 Data Supports Advancement
June 04, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8388844 for the full story. Read More
from StreetInsider.com News Articles
Stocks to Shrug Off Blood-Pressure Drug Dispute
May 31, 2013
A heated dispute within the FDA on whether to put new lung-cancer warnings on leading blood-pressure drugs taken by millions of people is unlikely to have any significant effect on the stocks of the... Read More
category Drugs , Novartis AG , Consumer Staples/Food and Staples Retailing/Drug Retail , and 6 more.
from CNBC.com News
Bio-Wire Equity Surveillance – Closing Bell 5/31/2013
May 31, 2013
Friday May 31st, 2013 Overview The market saw a nasty bearish reversal in the afternoon, which hit the healthcare sector just as badly as the rest of the market (if not a little worse in the high beta... Read More
category Bio/Wire
from Bio-Wire.Com
Aegerion cholesterol drug is recommended for approval in Europe
May 31, 2013
A committee has recommended a cholesterol drug developed by Aegerion Pharmaceuticals Inc. (Nasdaq:AEGR) to be approved in Europe, a positive sign for ultimate approval of the drug by the end of... Read More
category Health Care , Technology , Genzyme , and 4 more.
from Business Journals
Bio-Wire Equity Surveillance – Closing Bell 5/30/2013
May 30, 2013
Thursday, May 30th, 2013 Overview It was a very bullish day, particularly for the biotech sector. Large pharmaceutical companies (>$10 B) moved an average of +.6%, while medium sized companies moved... Read More
category AMRN , SRPT , CLSN , and 5 more.
from Bio-Wire.Com
Pfizer, UCSF expand scope of drug research deal
May 29, 2013
Pfizer Inc. and UCSF will expand a 2-1/2-year-old drug-research deal to include small molecules, making it possibly the only academic-industry research collaboration encompassing oral small-molecule... Read More
category Biotech , Education , Health Care , and 7 more.
from Business Journals
MassBio taps life science execs to lead new forums
May 29, 2013
The Massachusetts Biotechnology Council, MassBio, has named 51 people to its new advisory groups, formed to support the organization’s forums, panels and networking sessions... Read More
category Michael G/ Donovan , Howard Lefkin , Larry Wittenberg , and 56 more.
from Business Journals
Biogen Idec's MS Drug Launch Is Going Amazingly Well. These Two Graphs Prove It
May 29, 2013
Biogen Idec shares are up 60% since I profiled the company in Forbes in December. The reason's pretty simple: sales of the MS drug Tecfidera are basically destroying what were already very high... Read More
category NYSE:NVS , NYSE:SNY , NASDAQ:BIIB
from Forbes Real Time
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE

1
The Future of Android Looks More Like Apple Inc.
Mike Schuster
2
The Waning Integrity of US Financial Markets
Todd Harrison
3
The QE Carry Trade Is Imploding Right Under Everyone's Noses
Vince Foster
4
Immunotherapy: Four Companies on the Verge of Cancer-Treatment Breakthroughs
TM Meyer
5
Why Apple Inc. Can't Be Forgiven for iOS 7
Mike Schuster